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Abstract
Purpose Complete fracture healing is crucial for good patient
outcomes. A major complication in the treatment of fractures
is non-union. The pathogenesis of non-unions is not always
clear, although implant-associated infections play a significant
role, especially after surgical treatment of open fractures. We
aimed to evaluate the value of [18F]FDG PET in suspected
infections of non-union fractures.
Methods We retrospectively evaluated 35 consecutive pa-
tients seen between 2000 and 2015 with suspected infection
of non-union fractures, treated at a level I trauma center. The
patients underwent either [18F]FDG PET/CT (N = 24),
[18F]FDG PET (N = 11) plus additional CT (N = 8), or conven-
tional X-ray (N = 3). Imaging findings were correlated with
final diagnosis based on intraoperative culture or follow-up.
Results In 13 of 35 patients (37 %), infection was proven by
either positive intraoperative tissue culture (N = 12) or positive
follow-up (N = 1). [18F]FDG PET revealed 11 true-positive,
19 true-negative, three false-positive, and two false-negative
results, indicating sensitivity, specificity, positive predictive
value (PPV), negative predictive value (NPV), and accuracy
of 85 %, 86 %, 79 %, 90 %, and 86 %, respectively. The
SUVmax was 6.4 ± 2.7 in the clinically infected group and
3.0 ± 1.7 in the clinically non-infected group (p <0.01). The
SUVratio was 5.3 ± 3.3 in the clinically infected group and 2.6
± 1.5 in the clinically non-infected group (p <0.01).
Conclusion [18F]FDG PET differentiates infected from non-
infected non-unions with high accuracy in patients with
suspected infections of non-union fractures, for whom other
clinical findings were inconclusive for a local infection.
[18F]FDG PET should be considered for therapeutic manage-
ment of non-unions.
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Introduction
Approximately 5–10 % of fractures fail to heal properly, qual-
ifying as delayed union or persistent non-union fractures [1].
Non-unions are radiologically classified as atrophic, oligotro-
phic, or hypertrophic, based in part on the particular patho-
genesis of the non-union, which thus has an impact on further
treatment options [2]. The occurrence of infection at the site of
non-union is a major issue in selecting appropriate treatment;
infection is considered the worst prognostic factor in tibia
fracture care [3]. When stable fracture fixation can be con-
firmed, the presence of a bacterial infection is a possible rea-
son for the persistence of a non-union [4]. The treatment al-
gorithm in such cases becomes more radical and aggressive
debridement, with installation of an external fixator.
The presence of an acute infection may be obvious due to
open draining wounds, erythema, or incomplete soft tissue
coverage. However, swelling, erythema, and hyperthermia
can be suggestive of an infection, while merely indicating
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instability and local inflammatory reaction. Furthermore, a
bacterial infection at the site of non-union can be subacute
or chronic, and consequently more difficult to diagnose.
Besides the clinical aspects, the diagnosis of infection is sup-
ported by laboratory blood tests such as C-reactive protein
(CRP), erythrocyte sedimentation rate (ESR), and peripheral
leukocyte count. However, these laboratory tests are neither
highly sensitive nor specific for infection as a cause of non-
union. The gold standard proof of infection is from histolog-
ical examination and pathogen-positive cell cultures of the
infected area, which requires invasive biopsy. Non-invasive
diagnostic tests include plain radiography, CT, ultrasonogra-
phy, infection scintigraphy, and MRI. It is the last approach
that may be the first course of imaging work-up of a suspected
infection [5]. MRI can exclude osteomyelitis with high cer-
tainty [6]. However, it cannot distinguish with the same cer-
tainty between osteomyelitis and noninfectious causes of ab-
normal marrow signal intensity, such as neuropathic arthrop-
athy and reactive marrow edema [6]. Furthermore, MRI can
be hampered by the presence of screws, plates, or other me-
tallic devices at the site of bone injury [7].
In a previously published study, [18F]FDG PET demon-
strated high sensitivity in identifying the presence of osteomy-
elitis in orthopedic surgery patients with nonspecific clinical
symptoms of infection [8]. In a meta-analysis of studies on
suspected osteomyelitis, PET/CT with [18F]FDG has shown
promising sensitivity, specificity, and accuracy in comparison
to bone scintigraphy or leukocyte scintigraphy [9]. Despite
these findings, there has hitherto been no study systematically
evaluating [18F]FDG PET for diagnosis of suspected infec-
tions at non-union fractures. The aim of our study, therefore,
was to investigate whether increased [18F]FDG accumulation
in non-union fracture sites affords a non-invasive imaging
biomarker for infections in cases confirmed by intraoperative
tissue culture or clinical follow-up.
Methods
Patient population
This study was approved by the institutional ethics committee.
From a large PET database at the University of Munich, we
retrospectively identified 35 patients with suspected infection
of non-union fractures who had been treated in a level I trauma
center. The patients had undergone either [18F]FDG PET/CT
(N = 24), [18F]FDG PET (N = 11) with additional CT (N = 8),
or conventional X-ray (N = 3) between 2000 and 2015.
Patients presented with persistent pain at the fracture site and
may have also reported abnormal movement or clicking at the
level of the fracture. The geneses of the non-unions were
trauma, wedge osteotomy, osseous segment transport, and ar-
throdesis or fatigue fractures. Clear clinical markers for acute
local infection such as fistulas or pyrophoric wounds, erythema,
and/or hyperthermia were absent. Laboratory findings (CRP,
leukocytes), risk factors (atherosclerosis, alcohol, adiposity,
vascular disease, history of infection, smoking or nicotine use,
neurology, gout, and renal insufficiency), a surgically implanted
metallic device, gender, age, body mass index (BMI), and
location of injury were recorded. At the time of the [18F]FDG
PET scan, patients were not being treated with antibiotics.
[18F]FDG PET and PET/CT scan
Partial-body PET scans were acquired in three-dimensional
(3D) mode using different PET scanners (N = 5 GE
Discovery 690 CT, N = 11 ECAT PET scanner, N = 14
Philips Gemini CT, N = 5 Siemens BioGraph 64). Among
the 35 patients, 24 had undergone an [18F]FDG PET/CT,
and 11 had undergone only standalone [18F]FDG PET.
Based on the National Electrical Manufacturers Association
(NEMA) NU2-2001 standard, phantom studies were conduct-
ed, and standardized uptake value (SUV) conversion factors
were calculated to allow valid pooling of the results. After
patients had fasted for at least 6 h and blood glucose levels
were measured to exclude cases of blood glucose levels above
150 mg/dL (mean 97 ± 10 ng/mL prior to scan), a diuretic was
administered intravenously (furosemid, Furorese 20 mg;
Hexal AG, Holzkirchen, Germany), closely followed by bolus
administration of [18F]FDG (mean 254 ± 72 MBq) according
to body mass. The emission recording sequence was initiated
60 min after intravenous injection of [18F]FDG. Attenuation
correction was based on either CTor an external rotating 68Ge
source. CT was performed as high-dose CT (automated dose
modulation, mean 220 mAs; 120 kV, CT slice 3 mm) with
(N = 20) or without contrast agent (N = 4). When contrast
agent was administered prior to the CT scan, it consisted of
a mean weight-adapted volume of 120 mL iodine-containing
contrast agent (iomeprol, Imeron® 350 mg iodine/mL, Bracco
Imaging Deutschland GmbH, Konstanz, Germany), adminis-
tered intravenously at a rate of 2.5 mL/s; the CT scan was
initiated 50 s after the beginning of the infusion of contrast
agent in order to depict the venous contrast medium phase. A
dedicated software package was used for image reading
(Hermes Hybrid Viewer, version 2.0; Hermes Medical
Solutions, Stockholm, Sweden). In the present retrospective
study, the images were interpreted by consensus of two expe-
rienced nuclear medicine physicians and a radiologist, who
were blinded to bacteriological and surgical data and the pa-
tients’ clinical follow-up.
Image interpretation
For image interpretation, we performed quantitative SUV-
based analysis, visual analysis, and a combination of both
assessments.
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1. SUV-based analysis
Within the SUV based analysis, we performed further
receiver operating characteristic (ROC) analysis to obtain
a cut-off value. Consequently, all patients with SUVmax
greater than the cut-off value were rated positive, and
those with SUVmax less than the cut off-value were rated
negative for infection.
2. Visual analysis
We interpreted images positive for infection of the non-
union using two different criteria.
First set: The first qualitative set considered the mere
presence of [18F]FDG activity—whether homogenous
or focal—at the bone–bone interface or the prosthesis–
bone interface as indicative of infection, regardless of
intensity.
Second set: On the basis of two previously pub-
lished approaches [10, 11], we defined infection as
follows:
Positive for infection:
& [18F]FDG uptake was asymmetric compared to that in the
contralateral extremity, and
& [18F]FDG uptake was focally accentuated at the bone–
bone, bone–implant, or bone–soft tissue interface, thus
constituting a distinct Bhotspot^, and
& [18F]FDG uptake detected along the course of the non-
union fracture was at least twice the mean uptake of inac-
tive muscle from the contralateral extremity (SUVmax
[fracture] > 2 x SUVmean [muscle]).
Negative for infection:
& little [18F]FDG uptake, and no excessive increase in
uptake;
& in the case of weakly elevated [18F]FDG uptake, the up-
take pattern was smooth and evenly distributed along the
entire surface of the fracture line or along the surface of the
prosthesis;
& no distinct foci were discernible;
& a weak [18F]FDG uptake at the end of metallic
dev i c e s , whe r e movemen t i s mechan i c a l l y
constrained, and a weak [18F]FDG uptake which could
be unequivocally attributed to the part of the bone
experiencing the highest mechanical stress, e.g.
weight-loading.
3. Combination of visual diagnosis and SUV-based
diagnosis
In addition to these analyses, we performed a com-
bination of the second set of visual analysis and the
SUV-based diagnosis. In this approach, [18F]FDG
PET was rated as positive only if visual assessment
and SUV-based analysis were concordant.
Results validation
PET findings were verified by intraoperative tissue cultures
(N = 25) or long term clinical follow-up for more than one
year (N = 10). The clinical assessment and other follow-up
data were registered during regular visits to the trauma center.
True positive (TP), true negative (TN), false positive (FP),
and false negative (FN) were defined as follows:
TP:
& A positive PET result according to the above definitions,
and
& positive intraoperative bone microbiology or, in the case
of follow-up, a radiologically and clinically eventful
follow-up with the occurrence of clinical symptoms such
as pain at the infection site, drainage from the area, fever,
tenderness, redness, and warmth or swelling around the
affected bone, lost range of motion, or increasing labora-
tory parameters for infection (leukocytes, CRP level);
TN:
& negative PET result according to our given definitions,
and
& negative intraoperative bone microbiology or, in the case
of follow-up, a radiologically and clinically uneventful
follow-up without clinical symptoms, and with normal
infection parameters with no further therapy for at least
one year;
FP:
& positive PET result according to our given definitions, and
& negative intraoperative bonemicrobiology or negative fol-
low-up;
FN:
& negative PET result according to our given definitions,
and
& positive intraoperative bone microbiology or negative fol-
low-up.
Statistical analysis
Statistical analyses were performed using the SPSS statistical
software package (version 22.0; IBM Corp., Armonk, NY,
USA). A p value of less than 0.05 was considered statistically
significant. Comparisons of variables between clinically infect-
ed and non-infected groups were performed using the t test for
parametric data, the chi-square test for ordinal data, and the
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Mann–WhitneyU test for nonparametric data. Sensitivity, spec-
ificity, positive predictive value (PPV), and negative predictive
value (NPV) were calculated by comparing the PET results to
intraoperative findings or clinical follow-up.
Results
Patient cohort
A general overview of clinical and patient data is given in
Table 1.
In 13 of the 35 patients (37 %), infection was proven
either by positive intraoperative tissue culture (N = 12) or
by positive follow-up (N = 1). Infections were caused by a
single gram-posi t ive pathogen in nine pat ients
(Streptococcus epidermidis, N = 3; Streptococcus aureus,
N = 3; Enterococcus faecalis, N = 1; Staphylococcus
capitis N = 2) and by mixed infections in three patients
(Streptococcus epidermidis, Streptococcus aureus, group
A ß-hemolyt ic streptococcus , Pseudomonas , and
Escherichia coli). In the remaining 22 patients (63 %),
there was no evidence of infection. In 12 patients
(38 %), the [18F]FDG PET scan was performed in the
presence of metallic implants. Specifically, seven patients
had been treated with plate osteosynthesis, two patients
with intramedullary nail, and one patient each by screws,
by external fixation along with inserted screws, and with
combined plate osteosynthesis of the fibula and
intramedullary nail placement in the tibia. Non-union
Table 1 Patient characteristics
for patients with or without
evidence of clinical infection










Age (years) (mean ± SD) 53 ± 11 47 ± 5 50 ± 15
Gender Female 3 3 6
Male 10 19 29
Infection proven by Intraoperative microbial
bone culture
12 13 25
Follow-up > 1 year 1 9 10
CRP (mg/dL) (mean ± SD) 0.4 ± 0.2 0.5 ± 0.4 0.5 ± 0.3
Leukocytes (/nl) (mean ± SD) 8.0 ± 2.3 6.8 ± 1.6 7.2 ± 1.9
BMI (kg/m2) (mean ± SD) 27.2 ± 4.0 27.9 ± 5.1 27.6 ± 4.6
Location of non-union Femur 3 4 7
Tibia 7 10 17
Fibula 0 4 4
Tibia and fibula 1 1 2
Foot 1 2 3
Humerus 1 0 1
Patella 0 1 1
Risk factors None 2 (15 %) 3 (14 %) 5 (14 %)
Single 7 (54 %) 8 (36 %) 15 (43 %)
Multiple 4 (31 %) 11 (50 %) 15 (43 %)
Adiposity 4 7 11
History of infection 1 8 9
Nicotine 5 6 11
Alcohol 4 3 7
Vascular disease 2 3 5
Gout 0 2 2
Neurological symptoms 0 3 3
Diabetes 0 2 2
Renal insufficiency 1 0 1
COPD 1 0 1
Metallic implants Yes 6 6 12
No 7 16 23
Radiological
classification
Atrophic 5 6 11






(mean ± SD) 11.2 ± 6.1 16.9 ± 18.8 14.8 ± 15.4
PET/CT technique CTwith contrast 7 13 20
CTwithout contrast 1 3 4
PET only 5 6 11
NS non-significant,CRPC-reactive protein,BMI bodymass index,COPD chronic obstructive pulmonary disease
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types were classified as oligotrophic (N = 18), atrophic
(N = 11), and hypertrophic pseudarthrosis (N = 6) based
on radiological criteria. The mean time of persistence
of the non-unions was 14.8 (±15.4) months. There were
no statistical differences in patient characteristics bet-
ween the clinically infected and non-infected groups
(Table 1).
Results of [18F]FDG PET
The association of [18F]FDG-PET findings and labora-
tory findings, risk factors, BMI and radiological classi-
fication are listed in Table 2. Patient classification
according to type of non-union are shown in Table 3.
The results for the SUV-based, visual, and combined
analysis are presented in Table 4. Within the SUV-
based analysis, a cut-off value of 4.3 was obtained by
ROC analysis (AUC 0.848, sensitivity 75 %, specificity
77 %).
The best results were achieved by implementing the second
set of visual analysis: [18F]FDG PET was rated positive for
infection in 14 of 35 patients (40 %). There were 11 TP, 19
TN, three FP, and two FN results, indicating 85 % sensitivity,
86 % specificity, 79 % PPV, 90 % NPV, and 86 % accuracy.
The [18F]FDG accumulation in infected non-unions was more
circumscribed than that in non-infected non-unions, and typi-
cally did not affect the entire surface of the fracture line. In
non-infected non-unions, we saw more homogenous
[18F]FDG uptake at the entire surface of the fracture line
(Figs. 1, 2, and 3). Furthermore, the uptake of infected non-
unions was significantly higher. The SUVmax (6.4 ± 2.7) in the
Table 2 [18F]FDG PET
findings* according to normal or
abnormal laboratory findings, risk
factors, BMI, and radiological
classification of non-unions










CRP level (N = 31) <0.3 mg/dL 5 9 14
≥0.3 mg/dL 7 10 17
Leukocytes (N = 31) 4.3 to 10.8/nl 11 19 30
≥10.8/nl 1 0 1
Risk factors (N = 35) None 3 2 5
Single 6 9 15
Multiple 5 10 15
BMI (kg/m2)
(N = 34)
18.5 to <25 kg/m2 6 4 10
≥25 to <30 kg/m2 6 8 14
≥30 kg/m2 2 8 10
Type of non-union (N = 35) Atrophic 5 6 11
Oligotrophic 8 10 18
Hypertrophic 1 5 6
Normal values: CRP <0.3 mg/dL; leukocytes 4.3–10.8/nl
*Based on the second set of visual analysis
BMI body mass index, NS non-significant












second set of visual
analysis
TP 9 11 11 8
TN 17 9 19 20
FP 5 14 3 2
FN 4 1 2 5
Sensitivity 69 % 91 % 85 % 62 %
Specificity 77 % 39 % 86 % 91 %
PPV 64 % 44 % 79 % 80 %
NPV 81 % 90 % 90 % 80 %
Accuracy 74 % 57 % 86 % 80 %
TP True positive, TN true negative, FP false positive, FN false negative,
PPV positive predictive value, NPV negative predictive value
Table 3 Classification of patients according to type of non-union*
Types of non-union No. TP TN FP FN
Atrophic 11 4 (36 %) 5 (45 %) 1 (9 %) 1 (9 %)
Oligotrophic 18 7 (39 %) 9 (50 %) 1 (6 %) 1 (6 %)
Hypertrophic 6 0 (0 %) 5 (83 %) 1 (17 %) 0 (0 %)
*Based on the second set of visual analysis
TP True positive, TN true negative, FP false positive, FN false negative
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clinically infected non-union group was significantly higher
than that in the non-infected group (3.0 ± 1.7; p < 0.01).
Similarly, the mean SUVratio in the infected group (5.3 ± 3.3)
was higher than that in the non-infected group (2.6 ± 1.5;
p<0.01).
Applying the second set of visual analysis [18F]FDG PET
revealed four TP, five TN, one FP, and one FN case among the
atrophic non-unions; seven TP, nine TN, one FP, and one FN
for the oligotrophic non-unions; and five TN and one FP case
among the instances of hypertrophic non-unions (Table 3).
Fig. 2 44-year-old patient with
oligotrophic non-union fracture of
the distal tibia. No complete
osseous consolidation was seen
for 16 months. [18F]FDG uptake
was seen along the bone–bone
interface of the distal tibia. The
[18F]FDG uptake was focally
increased (SUVmax 4.2, SUVratio
3.1) at the distal part of the
proximal bone segment. Only the
first and second sets of visual
analysis were interpreted as
infection of the non-union (true
positive). The intraoperative
tissue culture was positive
Fig. 1 55-year-old patient with
oligotrophic non-union. No
complete osseous consolidation
was seen for 6 months.
Pathological, irregularly
distributed [18F]FDG uptake
(SUVmax 7.7, SUVratio 7.4) was
found along the bone–bone
interface, with a clear Bhotspot^
along the lateral fissure of the
femur. The elevated [18F]FDG
uptake extends to the proximate
soft tissue. Atrophy of the
M. vastus lateralis is seen due to
immobilization. The [18F]FDG
PET/CT scan was rated true
positive in all image analysis
based on positive intraoperative
microbial tissue culture
Eur J Nucl Med Mol Imaging (2017) 44:432–440 437
Discussion
Infection at the site of a fraction can delay union, or can result
in a non-union, which is a potentially disabling persistent fail-
ure of fracture healing. By definition, a non-union will not
heal unless properly treated in accordance with the cause of
the failure. It is of the utmost importance, therefore, to rule out
suspected infection in cases of non-union fractures so as to
facilitate timely and appropriate surgical fixation treatments.
While several imaging modalities have found use in the inves-
tigation of potentially infected non-union fractures, [18F]FDG
PET has not hitherto been tested. We thus present the first
systematic evaluation of [18F]FDG PET exclusively in pa-
tients with non-union fractures and suspected infections.
We tested several approaches for evaluating the imaging
results. Applying the second set of the visual analysis,
[18F]FDG PET showed high diagnostic sensitivity of 85 %
and specificity of 86 %, which should afford a secure diagno-
sis of infected non-union fractures. Furthermore, the high
NPV of 90 % should help to avoid inappropriate attempts to
treat with antibiotics or surgical debridement when infection is
absent. Thus, we demonstrate that [18F]FDG PET reliably
differentiates infected and non-infected non-unions, and
should then be a useful adjunct for therapeutic management.
Metallic implants are vulnerable sites of postoperative in-
fection; in a previously published [18F]FDG PETstudy, a sub-
group of six of 22 patients with suspected metallic implant-
associated infections had non-union fractures. These six pa-
tients were rated as having TN findings [12], indicating that
[18F]FDG uptake at uninfected non-union sites is significantly
lower than that at the sites of actual infections. Another study
evaluated [18F]FDG PET/CT in trauma patients with
suspected chronic osteomyelitis [13]; the authors found that
six of 33 patients with suspected osteomyelitis had non-union
fractures, of which three were rated true positive, two as true
negative, and one as false positive, due to pronounced
[18F]FDG uptake within the area of the fracture, despite ab-
sence of infection. Our investigation in a larger series confirms
these preliminary published results [12, 13].
In the absence of infection, [18F]FDG accumulationmay be
elevated in non-union fractures due to imperfect fixation, with
sterile inflammation arising from the resultant friction.
However, we expected that the [18F]FDG uptake of the infect-
ed non-union should significantly exceed that seen with non-
infected non-union. Indeed, clear discernment of the distinc-
tion between aseptic inflammation and infection did not pose a
problem in the present study.
A standardized approach to the interpretation of [18F]FDG
PET for diagnosing infection in non-union fractures is pres-
ently lacking. In our study, no reliable SUV-based threshold
for more accurate diagnosis in individual patients emerged.
Likewise, it has been reported that there is no simple relation
between the probability of infection and the intensity of
periprosthetic activity [14]. Considering merely the presence
of activity at the bone–bone interface or the prosthesis–bone
interface cannot be unambiguously associated with infection.
These results are in line with previously published studies
addressing periprosthetic [18F]FDG uptake [10, 15, 16]. We
Fig 3 53-year-old patient with
atrophic non-union fracture after a
tibial wedge osteotomy. No
complete osseous consolidation
was seen for 9 months. [18F]FDG
PET scan showed only slight,
homogeneously distributed and
not focally accentuated uptake
(SUVmax 3.0, SUV ratio 1.8)
along the fracture gap, which was
fixed by a plate. The uptake was
rated positive for infection in the
first set of visual analysis (false
positive). The SUV-based
analysis, the second set of visual
analysis, and the combination of
both were rated negative for
infection (true negative). In the
follow-up, no infection was
observed
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find that the particular pattern of pathological uptake must be
considered. Applying the second set of visual analysis resulted
in achieving high sensitivity of 85 % and specificity of 86 %.
[18F]FDG uptake at the infection sites was focally increased,
and typically did not affect the entire surface of the non-union
fracture. Locally increased stress and local friction can also
lead to focally circumscribed uptake, which is generally less
pronounced than that due to infection. In non-infected non-
unions, [18F]FDG uptake was more homogenous along the
fracture line. These patterns are likely due to aseptic inflam-
mation provoked by persistent movement and friction along
the entire surface of the non-union fraction. Regarding the
pathological pattern in this visual analysis, the number of
false-positive findings was lower than in the SUV-based quan-
titative analysis. We thus concur with the findings of Chacko
et al. [16], who noted that the intensity of [18F]FDG uptake is
less informative than is the location of the increased signal.
The combination of the visual and quantitative analysis seems
to underperform the proposed visual method, because no di-
agnostically reliable SUVmax cut-off value could be identified.
Hypertrophic, oligotrophic, and atrophic radiographic ap-
pearance allows estimation of the degree of fracture stability
and also the biologic viability of the fracture fragments. It is
likely that different forms of fracture non-unions may be re-
sponsible for the differences in [18F]FDG uptake patterns. In
particular, we suppose that hypertrophic non-unions may have
a higher physiological [18F]FDG uptake than oligotrophic or
atrophic non-unions, due to more distinct bone remodeling. In
our study, hypertrophic non-union was radiologically diag-
nosed in six patients, of whom five were rated as true negative
and one as false positive. In that individual, hypertrophymight
have aggravated the diagnosis. However, the other five pa-
tients with hypertrophic non-union were rated correctly, thus
indicating that hypertrophy is not a contraindication for the
[18F]FDG PETmethod. Further studies are needed to examine
the diagnostic accuracy in the relatively rare patients with
hypertrophic non-union and suspected infections.
Contemporary nuclear medicine offers several imaging
modalities for use in diagnosing infection in bone. At present,
white blood cell (WBC)/bone marrow imaging is considered
the best functional diagnostic imaging test for infected pros-
thetic joints [14, 17]. The diagnostic value of combined imag-
ing with 111In-labeled leukocytes and 99mTc methylene
diphosphonate for the diagnosis of non-union fractures was
discussed in an earlier study [18], with the authors reporting
sensitivity, specificity, PPV, NPV, and accuracy of 86 %,
84 %, 69 %, 94 %, and 82 %, respectively. Except for the
lower PPV, these results seem comparable to those from our
second set of [18F]FDG PET visual analysis, which may call
into question the additional value of single-photon emission
computerized tomography (SPECT)/CT in WBC in patients
with suspicion of infection at non-union fractures. Thus far, no
multimodal imaging comparison has been performed
regarding diagnostic accuracy in patients with non-unions,
and the best imagingmodality for non-union fractures remains
to be identified. Images obtained with PET have much higher
resolution than scintigraphy images [19], and [18F]FDG PET
has an inherently high target-to-background ratio.
Furthermore, the procedure is widely available. Diagnostic
results from [18F]FDG PET can be secured within 2 h, which
is favorable for patient welfare. Our results indicate that
[18F]FDG PET/CTor [18F]FDG PETwith additional morpho-
logical imaging represents a plausible alternative for imaging
infections of non-unions.
Limitations
Although this retrospective study dealt with a larger group
than previously published works, the total number of patients
was relatively small. Thus, larger series of patients will be
needed to confirm our results. Unfortunately, we were not able
to perform a multi-modality imaging comparison of diagnos-
tic accuracy. However, it will eventually be important to as-
certain the diagnostic accuracy of MRI, [18F]FDG PET/CT,
and infection scintigraphy for the detection of infected non-
union fractures. Of note, our sensitivity and specificity values
were assessed in a homogeneous group of patients who were
not receiving any antibiotic medication at the time of the
[18F]FDG PET scan. Whether current antibiotic treatment
might impair sensitivity in the PET/PET-CT investigation
needs to be evaluated in a separate study. A major drawback
of [18F]FDG PET is the nonspecific uptake that may occur
adjacent to prostheses, in healing tissues, bone fractures, vari-
cose veins, and atherosclerotic lesions [20–22].
Conclusion
[18F]FDG PET differentiates infected and non-infected non-
unions with high accuracy in patients for whom clinical find-
ings are inconclusive for a local infection. This approach
should be considered for therapeutic management of non-
unions.
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